Skip To The Main Content
Other PDA Sites
PDA Letter
PDA Journal
PDA Connect
PDA Technical Report Portal
Get Involved
Become a Volunteer
Volunteer Opportunities
PDA Covid-19 Information
Join/Renew
|
Login
Login to Your PDA Account
Sign in
Don't have an account yet?
Create an Account
Forgot your username or password?
Recover account
Parenteral Drug Association
Connecting People, Science and Regulation
®
Parenteral Drug Association
Connecting People, Science and Regulation
®
Home
Events
Training
Topic Areas
Aseptic Processing & Sterilization
Biopharmaceuticals & Biotechnology
Manufacturing Science
Quality & Regulatory
Supply Chain & Outsourcing
Publications
Bookstore
PDA Journal
PDA Letter
Technical Reports
Global Community
Chapters
Interest Groups
Membership Directory
Member Resources
PDA Connect
Standards
Volunteer Opportunities
Technical Advisory Boards
Foundation
Join PDA
Press Releases
12/14/2020
Parenteral Drug Association Announces Partnership with MJM Global Brokerage Group
Enables Access to Healthcare Coverage for their members with Immediate Savings and Simple Enrollment
12/11/2020
PDA Announces Results of 2020 Board Election and First All-Female Executive Committee
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the results of the 2020 Board of Directors Election for the term beginning January 1, 2021.
10/09/2020
PDA Announces 2020 Drug Delivery Innovation Award Winners
Bethesda, Md., – The Parenteral Drug Association (PDA) announced the winners of the 2020 PDA Drug Delivery Innovation Awards at the 2020 PDA Universe of Pre-Filled Syringes and Injection Devices, Oct. 5-8, a virtual event. Awardees were recognized for their technical innovations in advancing the field of bio/pharmaceutical delivery devices.
08/25/2020
PDA and BioPhorum Consortium Complete Work on PUPSIT Research and Points to Consider
Bethesda, Md., – The Parenteral Drug Association (PDA) and BioPhorum today announced that the Sterile Filtration Quality Risk Management (SFQRM), jointly created by the two organizations, has completed its final publication to help clarify industry thinking on the implications of pre-use post-sterilization integrity testing (PUPSIT) of sterilizing filters. The work product includes two research papers and two points-to-consider technical documents.
08/04/2020
PDA Confirms U.S. FDA’s Douglas Throckmorton as an Opening Plenary Speaker for Virtual 2020 PDA/FDA Joint Regulatory Conference
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced that it has confirmed Douglas Throckmorton, MD, Deputy Director for Regulatory Programs, Center for Drug Evaluation and Research (CDER), U.S. FDA, as an opening plenary speaker of the 2020 PDA/FDA Joint Regulatory Conference, which will be held virtually Sept. 14 – 16.
07/23/2020
BSR/PDA Standard 02-201x Cryopreservation Standard Available for Public Comment
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of BSR/PDA Standard 02-201x, Cryopreservation of Cells for Use in Cell Therapies and Regenerative Medicine Manufacturing for public comment. To receive a copy of this draft standard, email PDA at
[email protected]
. The public comments period concludes September 7, 2020 EDT. There is no charge for the draft standard.
06/01/2020
PDA Launches New Website for the PDA Foundation, a 501(c)(3) Organization Site includes a donation section for companies to underwrite certain PDA activities
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of a new website for the PDA Foundation, a 501(c)(3) nonprofit founded in 1997 to help support PDA and other industry activities. This new website makes it easier for industry stakeholders to donate money for various activities, as it includes an online processing system.
04/23/2020
PDA Forms Coronavirus Pandemic Response Task Force, New Advanced Therapy Advisory Board
Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced two new volunteer opportunities and changes to its Board of Directors/Executive Committee following its spring Board of Directors meeting.
04/17/2020
PDA Announces Availability of ANSI/PDA Standard 001-2020 on Purchasing Controls
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the availability of ANSI/PDA Standard 001-2020, Enhanced Purchasing Controls to Support the Bio-Pharmaceutical, Pharmaceutical, Medical Devices, and Combination Products Industries, which was approved by the ANSI Board of Standards Review on March 13, 2020.
04/07/2020
Parenteral Drug Association Announces its 2020 – 2026 Strategic Plan
Bethesda, Md. – The Parenteral Drug Association, Inc. (PDA) today announced the availability of its 2020 – 2026 Strategic Plan, which was developed to assist PDA in achieving its vision to be the premier global leader in advancing bio/pharmaceutical manufacturing, science, technology, and regulation to enable members to better serve patients. The plan was developed by PDA’s Strategic Planning Committee at the direction of the PDA Board of Directors.
03/27/2020
Parenteral Drug Association Announces Measures to Support Pharma/Biopharma Industries during Covid-19 Pandemic
Bethesda, Md. – The Parenteral Drug Association (PDA) announced that it is suspending membership expirations retroactively to March 1 and continuing until the end of June. All members will continue to enjoy the benefits of membership, even if you are unable to pay due to the impact of the corona virus pandemic.
03/10/2020
PDA Names Former Eli Lilly Exec. Glenn E. Wright Vice President of Scientific and Regulatory Affairs Dr. Tina Morris is leaving PDA to become Executive Director at AAPS
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced the appointment of former Eli Lilly and Co. - Executive Glenn E. Wright as Vice President of Scientific and Regulatory Affairs, effective March 23. Mr. Wright most recently worked as Senior Director of Quality Operations at Exelead, a contract manufacturer. Mr. Wright also has worked for Amgen and Pfizer.
02/12/2020
PDA Europe Parenteral Packaging to Address EU MDR 117 and Closed Systems
Berlin – Parenteral Drug Association Europe (PDA EU) is hosting its 10th Parenteral Packaging Conference in Basel, Switzerland, 25-26 February. The conference features presentations and discussions by industry leaders and technical experts from pharma and supplier companies. This year’s event includes expert discussions on the EU’s Medical Device Regulation 117 and on closed system transfer devices.
02/05/2020
PDA and AAMI Announce Plans to Explore Collaborations
Bethesda, Md. – The Parenteral Drug Association (PDA) and the Association for the Advancement of Medical Instrumentation (AAMI) today announced their agreement to explore collaborations to further the missions of both organizations and enhance value to their members, stakeholders, and their respective communities at large. The two heads of each organization met at PDA’s headquarters on Jan. 29 to sign a collaboration agreement.
01/28/2020
PDA Announces 2020 United States Conference Schedule
Bethesda, Md. – The Parenteral Drug Association (PDA) today announced its schedule of U.S. conferences for the year. The busy schedule includes PDA’s signature events and new “hot topic” workshops.
Press Releases Archive
2023
(8)
2022
(9)
2021
(8)
2020
(15)
2019
(21)
2018
(16)
2017
(14)
2016
(13)
2015
(18)
2014
(14)
2013
(12)
2012
(8)
2011
(6)
2010
(9)
2009
(15)
2008
(3)
Quick Links
Annual Reports
Staff
PDA Foundation
Press Pass Request Form
Press Releases
2026 Strategic Plan
PDA History Book
PDA Governance Structure
Code of Conduct
Leadership
Login to Your PDA Account
Sign In
Signing In
Don't have an account yet?
Create an Account
Forgot your username or password?
Recover account